Increased serum C‐reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis

Publisher: John Wiley & Sons Inc

E-ISSN: 1872-034x|48|3|E311-E319

ISSN: 1386-6346

Source: HEPATOLOGY RESEARCH, Vol.48, Iss.3, 2018-02, pp. : E311-E319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract